Lockheed Martin Boeing: Which Stock to Buy This July
Two industry giants released mixed Q1 results, highlighting divergent paths for July. Lockheed Martin stays mission-f...
When To Adjust Your Budget For Financial Health
Adjust your budget when income, expenses, or goals change, ensuring your plan remains aligned with long-term financial health.
22,799 articles
Hynix’s Unraveling Faster Than SpaceX: IPO Watch 2026
SK hynix's IPO opened with fanfare but quickly cooled, echoing a SpaceX pattern. Investors are weighing whether the p...
MAGS Delivered 181% Since: Equal-Weight Tech Risk Emerges
The Roundhill Magnificent Seven ETF has delivered strong gains since its April 2023 start, but a growing concentratio...
Counties with Highest Property Taxes in California
In 2026, California's counties with highest property taxes are seeing bills rise as high-valued homes push costs up, ...
Skydance Eyes Warner Takeover as David Ellison’s Rise Emerges
Two decades after a flopped acting debut, David Ellison’s Skydance is moving from indie financier to potential indust...
Alpha’s Economic Influence Enormous: Side Hustles & Spending
Gen Alpha now commands a growing slice of the U.S. wallet, with direct spending power crossing the $112 billion mark ...
U.S. Treasurys Look Like a Hallmark Moment for Markets
Markets lean on Treasurys as the only credible anchor amid volatility. Analysts say the U.S. debt market remains the ...
Vertiv Stock Just Spiked Again as AI Cooling Demand Surges
Vertiv stock just spiked again as demand for AI-ready cooling infrastructure fuels a renewed rally. Analysts say the ...
Arizona’s Largest Shifts Independent: MLS Board Overhaul
ARMLS moves to an independent board with an advisory council to keep practitioner voices in governance. The transitio...
Aramco CEO Warns: Market Won’t Return Normal This Year
Aramco’s chief executive warned that the oil market won’t return normal this year if the Iran conflict isn’t resolved...
KeyBanc Just Hiked CrowdStrike Target to $700
KeyBanc boosted its outlook on CrowdStrike, lifting the price target to $700 after signals from the Mythos conference...
Forget Moderna: This Biotech Juggernaut Is Rising Fast
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status